Trimeda LT - Company finances
|
EUR
|
2019
From: 2019-08-23
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 4,189 | 7,620 | 6,079 | 2,555 | 3,016 | 1,378 | 3,185 |
| Profit before tax | 628 | 3,382 | 751 | -608 | -192 | 93 | -985 |
| Net profit | 628 | 3,258 | 708 | -608 | -192 | 93 | -985 |
| Equity | -875 | 2,383 | 8,091 | 4,493 | 4,300 | 4,393 | 3,408 |
| Liabilities | - | - | - | 3,044 | 2,996 | 1,997 | 0 |
| Non-current assets | 0 | 0 | 0 | 777 | 511 | 245 | 0 |
| Current assets | 6,384 | 7,563 | 8,422 | 6,760 | 6,785 | 6,145 | 3,408 |
| Total assets | 6,384 | 7,563 | 8,422 | 7,537 | 7,296 | 6,390 | 3,408 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 1 | - | - |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +81.9% | -20.2% | -58.0% | +18.0% | -54.3% | +131.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.8% | 43.1% | 8.4% | -8.1% | -2.6% | 1.5% | -28.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 136.7% | 8.8% | -13.5% | -4.5% | 2.1% | -28.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.0% | 42.8% | 11.6% | -23.8% | -6.4% | 6.7% | -30.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.0% | 44.4% | 12.4% | -23.8% | -6.4% | 6.7% | -30.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.7 | 0.7 | 0.5 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Trimeda LT - Social security debts
The company had no debts to Sodra
Trimeda LT - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Trimeda LT, MB (code 305235941) is a small partnership operating in wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €3.2K and recorded a net loss of €985, resulting in a profit margin of -30.9%. Revenue rebounded by 131.1% year on year from €1.4K in 2024, but this followed a weak 2024 base and did not translate into profitability. The broader two-year picture remains uneven: revenue fell from €3.0K in 2023 to €1.4K in 2024 before recovering in 2025, while results moved from a €192 loss in 2023 to a €93 profit in 2024 and back to a larger loss in 2025. At year-end 2025, total assets stood at €3.4K and equity at €3.4K. Liabilities were €3.0K in 2023 and €2.0K in 2024. The latest ROE and ROA were both -28.9%, and asset turnover was 0.93x. No staff data was provided, so revenue per employee cannot be assessed.